Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expression Patterns of the Immunosuppressive Proteins PD-1/CD279 and PD-L1/CD274 at Different Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Kanchan Kantekure, Yusong Yang, Puthiyaveettil N. Raghunath, et al.
American Journal of Dermatopathology (2011) Vol. 34, Iss. 1, pp. 126-128
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas
Aaron M. Goodman, Sandip Pravin Patel, Razelle Kurzrock
Nature Reviews Clinical Oncology (2016) Vol. 14, Iss. 4, pp. 203-220
Closed Access | Times Cited: 416
Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study
Michael S. Khodadoust, Alain H. Rook, Pierluigi Porcu, et al.
Journal of Clinical Oncology (2019) Vol. 38, Iss. 1, pp. 20-28
Open Access | Times Cited: 191
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
Darci J. Phillips, Magdalena Matusiak, Belén Rivero‐Gutiérrez, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 157
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
Wamidh H. Talib, Dima Awajan, Abdelrahim Alqudah, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1373-1373
Open Access | Times Cited: 29
Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
Thorbjørn Krejsgaard, Lise M. Lindahl, Nigel P. Mongan, et al.
Seminars in Immunopathology (2016) Vol. 39, Iss. 3, pp. 269-282
Open Access | Times Cited: 129
Differential Expression of Programmed Death-1 (PD-1) in Sézary Syndrome and Mycosis Fungoides
Fatma Çetinözman, Patty M. Jansen, Maarten H. Vermeer, et al.
Archives of Dermatology (2012) Vol. 148, Iss. 12, pp. 1379-1379
Closed Access | Times Cited: 120
PD‐1/PD‐L1 inhibitors in haematological malignancies: update 2017
Tomáš Jelı́nek, Jana Mihályová, Michal Kaščák, et al.
Immunology (2017) Vol. 152, Iss. 3, pp. 357-371
Open Access | Times Cited: 114
Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade: A Key Player Against Various Cancers
Jian Guan, Khin Sandar Lim, Tarek Mekhail, et al.
Archives of Pathology & Laboratory Medicine (2017) Vol. 141, Iss. 6, pp. 851-861
Open Access | Times Cited: 108
Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile
Christiane Querfeld, Samantha Leung, Patricia L. Myskowski, et al.
Cancer Immunology Research (2018) Vol. 6, Iss. 8, pp. 900-909
Open Access | Times Cited: 91
Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
Thorbjørn Krejsgaard, Niels Ødum, Carsten Geisler, et al.
Leukemia (2011) Vol. 26, Iss. 3, pp. 424-432
Closed Access | Times Cited: 107
Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, et al.
Toxins (2013) Vol. 5, Iss. 8, pp. 1402-1421
Open Access | Times Cited: 84
New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
Kazuyasu Fujii
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 68
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders
Fanny Beltzung, Nicolás Ortonne, Laura Pelletier, et al.
The American Journal of Surgical Pathology (2020) Vol. 44, Iss. 7, pp. 862-872
Closed Access | Times Cited: 55
Expression of T-Follicular Helper Markers in Sequential Biopsies of Progressive Mycosis Fungoides and Other Primary Cutaneous T-Cell Lymphomas
Francesca Maria Bosisio, Lorenzo Cerroni
American Journal of Dermatopathology (2014) Vol. 37, Iss. 2, pp. 115-121
Closed Access | Times Cited: 62
PD-1-PD-L1 immune-checkpoint blockade in malignant lymphomas
Yi Wang, Ling Wu, Chen Tian, et al.
Annals of Hematology (2017) Vol. 97, Iss. 2, pp. 229-237
Closed Access | Times Cited: 51
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Ieva Saulīte, Desislava Ignatova, Yun‐Tsan Chang, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 40
Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study
Luojun Wang, Delphine Rocas, Stéphane Dalle, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 6, pp. 970-980
Open Access | Times Cited: 23
Clinical, Pathologic, and Molecular spectrum of Angioinmmunoblastic T-cell Lymphoma Cutaneous Lesions
Francisco Javier Díaz de la Pinta, M. Ángeles Pérez-Guillermo Cuevas, Rebeca Manso, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome
Howard Meyerson, Amad Awadallah, Peter Pavlidakey, et al.
Modern Pathology (2012) Vol. 26, Iss. 1, pp. 32-43
Open Access | Times Cited: 57
The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma
Ronnie M. Abraham, Qian Zhang, Niels Ødum, et al.
Cancer Biology & Therapy (2011) Vol. 12, Iss. 12, pp. 1019-1022
Open Access | Times Cited: 57
Cutaneous T cell lymphoma cells are targets for immune checkpoint ligand PD-L1-specific, cytotoxic T cells
Shamaila Munir Ahmad, G H Andersen, Anders Woetmann, et al.
Leukemia (2013) Vol. 27, Iss. 11, pp. 2251-2253
Closed Access | Times Cited: 45
Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Bei Hu, Ryan Jacobs, Nilanjan Ghosh
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 543-554
Closed Access | Times Cited: 40
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
Pietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 3, pp. 484-495
Open Access | Times Cited: 34
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
Katherine Case, Pamela B. Allen
Current Hematologic Malignancy Reports (2025) Vol. 20, Iss. 1
Closed Access
Expression of Follicular Helper T-cell Markers in Primary Cutaneous T-cell Lymphoma
Ji‐Hye Park, Jae Ho Han, Hee Young Kang, et al.
American Journal of Dermatopathology (2013) Vol. 36, Iss. 6, pp. 465-470
Closed Access | Times Cited: 41
Page 1 - Next Page

Scroll to top